These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 6519853

  • 1. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol.
    Belogi M, Ansuini R, Pupita G, Campolucci G, Pupita F.
    Int J Clin Pharmacol Res; 1984; 4(5):385-7. PubMed ID: 6519853
    [Abstract] [Full Text] [Related]

  • 2. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S, Nielsen PE.
    Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
    [Abstract] [Full Text] [Related]

  • 3. [Labetalol for the management of hypertensive crises during surgery of cerebral aneurysm; a haemodynamic study (author's transl)].
    Lüben V, Rieder W, Zierski J, Hempelmann G.
    Anasth Intensivther Notfallmed; 1981 Aug; 16(4):184-7. PubMed ID: 7294326
    [Abstract] [Full Text] [Related]

  • 4. [Hypotensive effect and changes of arterial pressure variability induced by treatment with labetalol in patients with slight and moderate arterial hypertension].
    Palatini P, Pessina AC, Sperti G, Ventura E, Agnoletto V, Semplicini A, Hlede M, Gava R, Mormino P, Dal Palù C.
    G Ital Cardiol; 1983 Aug; 13(1):18-22. PubMed ID: 6873535
    [Abstract] [Full Text] [Related]

  • 5. [Systolic time intervals in essential hypertension. II. Variations produced by treatment with labetalol].
    Rossi A, Ziacchi V, Lomanto B.
    Arch Mal Coeur Vaiss; 1979 Nov; 72(11):1240-6. PubMed ID: 121529
    [Abstract] [Full Text] [Related]

  • 6. The use of systolic time intervals in the evaluation of antihypertensive treatment with metoprolol, labetalol and prazosin.
    Buch J, Rasmussen S.
    Cor Vasa; 1983 Nov; 25(5):358-66. PubMed ID: 6653128
    [Abstract] [Full Text] [Related]

  • 7. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
    la Cour Petersen E, Kristensen BO.
    Postgrad Med J; 1980 Nov; 56 Suppl 2():60-4. PubMed ID: 7433345
    [Abstract] [Full Text] [Related]

  • 8. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
    Pupita F, Ansuini R, Belogi M, Pupita G, Gaggi S.
    Int J Clin Pharmacol Res; 1985 Nov; 5(6):439-45. PubMed ID: 2869001
    [Abstract] [Full Text] [Related]

  • 9. Haemodynamic effects of long-term oral labetalol.
    Edwards RC, Raftery EB.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [Abstract] [Full Text] [Related]

  • 10. [Action of labetalol on heart rate, arterial pressure and systolic time intervals at rest and during exercise in hypertensive subjects].
    Cherchi A, Raffo M, Sau F, Seguro C, Pirisi R.
    Boll Soc Ital Cardiol; 1978 Aug; 23(1):158-76. PubMed ID: 754770
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
    Hauger-Klevene JH.
    Pharmatherapeutica; 1981 Aug; 3(1):46-54. PubMed ID: 7033992
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of methyldopa and labetalol in the treatment of hypertension.
    Sanders GL, Davies DM, Gales GM, Rao JG, Rawlins MD, Routledge PA.
    Br J Clin Pharmacol; 1979 Aug; 8(Suppl 2):149S-151S. PubMed ID: 393286
    [Abstract] [Full Text] [Related]

  • 13. Double-blind trial of labetalol.
    Kane J, Gregg I, Richards DA.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [Abstract] [Full Text] [Related]

  • 14. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
    Besterman EM, Spencer M.
    Br J Clin Pharmacol; 1979 Aug; 8(Suppl 2):205S-209S. PubMed ID: 526402
    [Abstract] [Full Text] [Related]

  • 15. Labetalol infusion in acute myocardial infarction with systemic hypertension.
    Marx PG, Reid DS.
    Br J Clin Pharmacol; 1979 Aug; 8(Suppl 2):233S-238S. PubMed ID: 526407
    [Abstract] [Full Text] [Related]

  • 16. [Cardiovascular effects of acute administration of labetalol in hypertensive patients].
    Novo S, Pinto A, Davì G, Riolo F, Gullotti D.
    Boll Soc Ital Cardiol; 1980 Aug; 25(2):149-56. PubMed ID: 7016144
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of labetalol and propranolol in treatment of hypertension.
    Harvald B.
    Postgrad Med J; 1980 Aug; 56 Suppl 2():65-8. PubMed ID: 7433346
    [Abstract] [Full Text] [Related]

  • 18. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J, Zech PY, Pozet N, Cuisinaud G, Vincent M.
    J Pharmacol; 1983 Aug; 14 Suppl 2():121-9. PubMed ID: 6355664
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of arterial hypertension with labetalol. A polycentric study].
    G Ital Cardiol; 1982 Aug; 12(10):729-35. PubMed ID: 7182212
    [Abstract] [Full Text] [Related]

  • 20. Experience with labetalol in hypertension.
    Bolli P, Waal-Manning J, Wood AJ, Simpson FO.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.